McClung David 4
4 · BioCardia, Inc. · Filed Oct 16, 2024
Insider Transaction Report
Form 4
BioCardia, Inc.BCDA
McClung David
Chief Financial Officer
Transactions
- Award
Common Stock
2024-10-11$2.65/sh+24,193$64,111→ 41,573 total - Tax Payment
Common Stock
2024-10-11$2.65/sh−11,565$30,647→ 30,008 total
Footnotes (2)
- [F1]The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock awarded as compensation in lieu of cash. 100% of the RSUs vested on October 11, 2024.
- [F2]The reported securities represent the shares that have been withheld by the Issuer to satisfy its income tax, withholding and remittance obligations in connection with the net settlement of the RSUs vested on October 11, 2024 and does not represent a sale by the Reporting Person.